MOCA Health: Supplying GMP-Certified Medical Cannabis to Canada
Medicinal Organic Cannabis Australia (MOCA) Pty Ltd owns and operates an import/export business supplying medical cannabis to the pharmaceutical industry. With full licensing and export approvals from the Australian Office of Drug Control, MOCA specialises in supplying international markets with GMP-certified, Australian-grown medical cannabis in both raw and finished product formats.
Canada is one of the world’s most advanced medical cannabis markets, with a well-established regulatory framework and a strong demand for high-quality cannabis products. As one of the first countries to legalise cannabis for medical use, Canada has developed a sophisticated distribution network, with pharmaceutical companies and dispensaries offering a wide range of cannabis-based therapies. The market continues to grow, driven by increasing patient access and evolving healthcare policies that integrate medical cannabis as a therapeutic option.
MOCA ensures that all medical cannabis products meet stringent Australian and international regulatory requirements. Our products are:
GMP-Certified: Manufactured under Good Manufacturing Practice (GMP) standards, ensuring pharmaceutical-grade quality and consistency.
TGA-Compliant: Fully compliant with the Australian Therapeutic Goods Administration (TGA) guidelines, aligning with global regulatory standards.
Lab-Tested: Subjected to rigorous third-party laboratory testing to verify cannabinoid content, purity, and the absence of contaminants.
MOCA supplies a diverse portfolio of medical cannabis products, tailored to meet the needs of pharmaceutical distributors, healthcare providers, and patients in Canada. Our offerings include:
GMP-Certified Cannabis Flower: High-quality, Australian-grown cannabis available in various THC and CBD formulations.
Cannabis Oils and Extracts: Precision-dosed liquid formulations designed for controlled therapeutic use.
Isolated Cannabinoid Products: 99.9% pure CBD isolate and other cannabinoid extracts for pharmaceutical applications.
Reliable and Scalable Supply: As an established importer and exporter, MOCA has the capability to meet large-scale demands while ensuring a consistent supply chain.
Pharmaceutical-Grade Standards: Our strict adherence to GMP regulations guarantees product safety and efficacy.
Regulatory Expertise: With in-depth knowledge of international cannabis regulations, MOCA ensures compliance with both Australian and international medical cannabis frameworks.
Customisable Formulations: We offer tailored product solutions to meet specific market requirements and patient needs.
Sustainable and Ethical Sourcing: MOCA prioritises environmentally responsible cultivation and production practices.
MOCA works closely with international partners to facilitate seamless entry into the Canadian medical cannabis market. Our compliance team ensures that all necessary documentation, including Certificates of Analysis (COA) and GMP certifications, are provided to streamline regulatory approvals for our pharmaceutical clients.
With Canada’s advanced medical cannabis framework and increasing patient demand, MOCA is well-positioned to support healthcare providers and distributors in delivering high-quality medical cannabis solutions to patients in need.
MOCA is actively seeking partnerships with Canadian pharmaceutical distributors, medical practitioners, and healthcare institutions looking to integrate premium, GMP-certified medical cannabis into their treatment protocols.
For inquiries on bulk supply, regulatory guidance, or customised product solutions, contact our international sales team today.